About: Concept Foundation

An Entity of Type: organisation, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

The Concept Foundation is a non-profit foundation which was established by the UNDP/UNFPA/WHO/WB Special program in Reproductive Health (WHO/HRP), PATH, the World Bank in 1989 in Bangkok, Thailand, "as a mechanism through which WHO’s rights associated with an injectable contraceptive, Cyclofem, could be licensed to potential producers in developing countries". Estradiol cypionate/medroxyprogesterone acetate (brand names Cyclofem, Lunelle; code name Cyclo-Provera), is a once-a-month combined injectable contraceptive which contains 25 mg of medroxyprogesterone acetate—the same ingredient in Depo Provera—and 5 mg of estradiol cypionate.

thumbnail
Property Value
dbo:abstract
  • The Concept Foundation is a non-profit foundation which was established by the UNDP/UNFPA/WHO/WB Special program in Reproductive Health (WHO/HRP), PATH, the World Bank in 1989 in Bangkok, Thailand, "as a mechanism through which WHO’s rights associated with an injectable contraceptive, Cyclofem, could be licensed to potential producers in developing countries". Estradiol cypionate/medroxyprogesterone acetate (brand names Cyclofem, Lunelle; code name Cyclo-Provera), is a once-a-month combined injectable contraceptive which contains 25 mg of medroxyprogesterone acetate—the same ingredient in Depo Provera—and 5 mg of estradiol cypionate. Since its inception in 1989, more than 120 million doses of Cyclofem have been manufactured and sold worldwide. Concept Foundation products have been manufactured in 8 different countries and are made available in more than 30 developing countries. (en)
dbo:thumbnail
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 7986129 (xsd:integer)
dbo:wikiPageLength
  • 2856 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1058676620 (xsd:integer)
dbo:wikiPageWikiLink
dbp:wikiPageUsesTemplate
dct:subject
gold:hypernym
rdf:type
rdfs:comment
  • The Concept Foundation is a non-profit foundation which was established by the UNDP/UNFPA/WHO/WB Special program in Reproductive Health (WHO/HRP), PATH, the World Bank in 1989 in Bangkok, Thailand, "as a mechanism through which WHO’s rights associated with an injectable contraceptive, Cyclofem, could be licensed to potential producers in developing countries". Estradiol cypionate/medroxyprogesterone acetate (brand names Cyclofem, Lunelle; code name Cyclo-Provera), is a once-a-month combined injectable contraceptive which contains 25 mg of medroxyprogesterone acetate—the same ingredient in Depo Provera—and 5 mg of estradiol cypionate. (en)
rdfs:label
  • Concept Foundation (en)
owl:sameAs
skos:closeMatch
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License